| Line Item | 2025-10-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $75.1M | +7.0% | -20.3% |
| Cost of Revenue | $44.8M | +2.2% | +22.7% |
| Gross Profit | $30.4M | +14.9% | -47.5% |
| R&D Expense | $58.4M | -9.7% | +4.7% |
| SG&A Expense | $25.8M | +7.1% | +18.5% |
| Operating Income | -$112.1M | +10.2% | -48.9% |
| Pre-tax Income | -$104.4M | +10.3% | -58.9% |
| Income Tax | $237K | -21.0% | -7.8% |
| Net Income | -$104.7M | +10.4% | -58.7% |
| EPS (Basic) | -$0.75 | +12.8% | -44.2% |
| EPS (Diluted) | -$0.75 | +12.8% | -44.2% |
| Line Item | 2025-10-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $103.2M | +27.5% | -14.9% |
| Short-term Investments | $571.8M | -9.4% | -6.1% |
| Accounts Receivable | $136.1M | +19.4% | -15.0% |
| Current Assets | $845.9M | -0.6% | -7.8% |
| Total Assets | $961.3M | -0.8% | -8.1% |
| Current Liabilities | $130.8M |
| Line Item | 2025-10-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$80.0M | -138.6% | — |
| Capital Expenditures | $1.1M | +50.8% | — |
| Investing Cash Flow | $10.9M | +121.3% | — |
| Financing Cash Flow | $8.0M | +517.6% | — |
| Free Cash Flow | -$81.2M | -136.7% | — |
| +7.2% |
| Total Liabilities | $189.4M | +11.5% | +1.1% |
| Stockholders' Equity | $771.9M | -3.4% | -10.1% |